ENANTA PHARMACEUTICALS INC — SC 13G/A Filings
48 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by ENANTA PHARMACEUTICALS INC (ENTA), sorted by most recent first. Each row links to the full filing on EdgarLookup. ENANTA PHARMACEUTICALS INC has filed 48 SC 13G/A documents with the SEC since 2002. To view all SEC filings by ENANTA PHARMACEUTICALS INC, see the full filings list.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFR14A
EFFECT
NT 10-Q
POSASR
REGDEX
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | — | 0001172661-24-005156 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001273087-24-000102 | Oct 17, 2024 | — |
| SC 13G/A | — | 0001172661-24-001225 | Feb 14, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020838 | Feb 13, 2024 | — |
| SC 13G/A | — | 0000908834-24-000024 | Jan 26, 2024 | — |
| SC 13G/A | — | 0001086364-24-002756 | Jan 24, 2024 | — |
| SC 13G/A | — | 0001306550-23-010049 | Oct 6, 2023 | — |
| SC 13G/A | — | 0001172661-23-001232 | Feb 14, 2023 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015863 | Feb 9, 2023 | — |
| SC 13G/A | AMENDMENT #4 | 0000908834-23-000024 | Feb 6, 2023 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-042398 | Feb 15, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-042205 | Feb 14, 2022 | — |
| SC 13G/A | AMENDMENT #3 | 0000908834-22-000087 | Feb 11, 2022 | — |
| SC 13G/A | — | 0001037389-22-000038 | Feb 10, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-22-017459 | Feb 10, 2022 | — |
| SC 13G/A | SC 13G/A | 0001104659-22-011970 | Feb 4, 2022 | — |
| SC 13G/A | — | 0000834237-22-003234 | Jan 28, 2022 | — |
| SC 13G/A | — | 0000080255-21-001201 | Feb 16, 2021 | — |
| SC 13G/A | AMENDMENT NO. 3 | 0001214659-21-001719 | Feb 16, 2021 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-21-017985 | Feb 10, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-008449 | Jan 28, 2021 | — |
| SC 13G/A | — | 0000080255-20-001241 | Feb 14, 2020 | — |
| SC 13G/A | AMENDMENT NO. 2 | 0001214659-20-001396 | Feb 14, 2020 | — |
| SC 13G/A | SC 13G/A | 0001193125-20-034700 | Feb 13, 2020 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-20-018170 | Feb 12, 2020 | — |
| SC 13G/A | — | 0000834237-20-001638 | Feb 4, 2020 | — |
| SC 13G/A | SC 13G/A | 0001104659-20-006199 | Jan 23, 2020 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0001214659-19-001111 | Feb 14, 2019 | — |
| SC 13G/A | NONE | 0001567619-19-002908 | Feb 11, 2019 | — |
| SC 13G/A | SC 13G/A | 0001144204-19-005714 | Feb 8, 2019 | — |
| SC 13G/A | — | 0000215457-19-001541 | Jan 28, 2019 | — |
| SC 13G/A | SC 13G/A | 0001144204-18-002989 | Jan 22, 2018 | — |
| SC 13G/A | — | 0000215457-18-001530 | Jan 19, 2018 | — |
| SC 13G/A | SC 13G/A | 0001104659-17-064383 | Oct 27, 2017 | — |
| SC 13G/A | SC 13G/A | 0001144204-17-003598 | Jan 24, 2017 | — |
| SC 13G/A | — | 0000869311-17-000392 | Jan 12, 2017 | — |
| SC 13G/A | — | 0000215457-16-007151 | Dec 9, 2016 | — |
| SC 13G/A | ENANTA PHARMACEUTICALS, INC. | 0001072613-16-000686 | Feb 19, 2016 | — |
| SC 13G/A | — | 0000315066-16-005064 | Feb 12, 2016 | — |
| SC 13G/A | CONSONANCE CAPITAL MANAGEMENT LP | 0001085146-16-002991 | Feb 11, 2016 | — |
| SC 13G/A | SC 13G/A | 0001144204-16-078709 | Feb 3, 2016 | — |
| SC 13G/A | — | 0000790502-16-000068 | Jan 25, 2016 | — |
| SC 13G/A | — | 0000315066-15-002660 | May 11, 2015 | — |
| SC 13G/A | SC 13G/A | 0001144204-15-010160 | Feb 17, 2015 | — |
| SC 13G/A | — | 0000315066-15-001873 | Feb 13, 2015 | — |
| SC 13G/A | SC 13G/A | 0001144204-15-007302 | Feb 10, 2015 | — |
| SC 13G/A | SC 13G/A | 0001104659-14-009826 | Feb 13, 2014 | — |
| SC 13G/A | — | 0000315066-14-001813 | Feb 10, 2014 | — |